A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having ...

It works by blocking a protein that stimulates platelets (blood components that help with normal clotting) to form a clot in response to bleeding. Like all drugs that interfere with blood clotting ...

This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for relieving Thrombocytopenia symptom. Learn about various drugs, from their ...

[2] In 1998 only one drug in this class was available, a monoclonal antibody (abciximab) directed against the fibrinogen receptor on the platelet surface GP IIb/IIIa. A more recently approved drug ...

Few clinical situations generate as much anxiety amongst physicians and surgeons as uncontrolled bleeding, particularly in patients with platelet abnormalities, such as reduced platelet number ...

Class, Polyphosphate (polyP)-Based Therapy, Show Promise in Bypassing P2Y12 Inhibition to Restore Normal Clotting Function ...

“Platelet transfusions are not particularly ... three from the surgery group and two from the major bleeding group — had drug-related adverse events, but there were no serious drug-related ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...

The pathogenesis of suboptimal platelet function is multifactorial. Platelets do not function well if there are too many or too few platelets; also the platelets can be present in the appropriate ...